Logo
BROWSE EVIDENCE REPOSITORY

 

Systematic reviews English (5) French All (5)

Cochrane Systematic Review: Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock (2013)

Visit

Alejandria Marissa MLMA, D.; Dans Leonila, F.; Mantaring, I. I. I. Jacinto Blas

Objectives: To estimate the effects of IVIG as adjunctive therapy in patients with bacterial sepsis or septic shock on mortality, bacteriological failure rates, and duration of stay in hospital. Published: 2013.

Systematic Review: Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis (2013)

Visit

Wacker CP, A.; Brunkhorst, F. M.; Schlattmann, P.

Background: Procalcitonin is a promising marker for identification of bacterial infections. We assessed the accuracy and clinical value of procalcitonin for diagnosis of sepsis in critically ill patients. Published: 2013.

Systematic Review: Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis (20

Visit

Yo CHH, P. S.; Lee, S. H.; Wu, J. Y.; Chang, S. S.; Tasi, K. C.; Lee, C. C.

Objective: We determine the usefulness of the procalcitonin for early identification of young children at risk for severe bacterial infection among those presenting with fever without source. Published: 2012.

Cochrane Systematic Review: Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients (2012)

Visit

Mart-Carvajal Arturo JS, Ivan; Gluud, Christian; Lathyris, Dimitrios; Cardona...

Background: Sepsis is a common and frequently fatal condition. Human recombinant activated protein C (APC) has been introduced to reduce the high risk of death associated with severe sepsis or septic shock. This systematic review is an update of a Cochrane review originally published in 2007.Objectives: We assessed the benefits and harms of APC for patients with severe sepsis or septic shock. Published: 2012.

Systematic Review: Early goal-directed therapy in severe sepsis and septic shock: a contemporary review of the literature (2008)

Visit

Rivers EPC, V.; Whitmill, M.

Objective: Aggressive approaches to acute diseases such as acute myocardial infarction, trauma, and stroke have improved outcomes. Early goal-directed therapy for severe sepsis and septic shock represents a similar approach. An analysis of the literature assessing external validity and generalizability of this intervention is lacking. Published: 2008.

Cochrane Systematic Review: Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock (2013)

Visit

Alejandria Marissa MLMA, D.; Dans Leonila, F.; Mantaring, I. I. I. Jacinto Blas

Objectives: To estimate the effects of IVIG as adjunctive therapy in patients with bacterial sepsis or septic shock on mortality, bacteriological failure rates, and duration of stay in hospital. Published: 2013.

Systematic Review: Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis (2013)

Visit

Wacker CP, A.; Brunkhorst, F. M.; Schlattmann, P.

Background: Procalcitonin is a promising marker for identification of bacterial infections. We assessed the accuracy and clinical value of procalcitonin for diagnosis of sepsis in critically ill patients. Published: 2013.

Systematic Review: Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis (20

Visit

Yo CHH, P. S.; Lee, S. H.; Wu, J. Y.; Chang, S. S.; Tasi, K. C.; Lee, C. C.

Objective: We determine the usefulness of the procalcitonin for early identification of young children at risk for severe bacterial infection among those presenting with fever without source. Published: 2012.

Cochrane Systematic Review: Human recombinant protein C for severe sepsis and septic shock in adult and paediatric patients (2012)

Visit

Mart-Carvajal Arturo JS, Ivan; Gluud, Christian; Lathyris, Dimitrios; Cardona...

Background: Sepsis is a common and frequently fatal condition. Human recombinant activated protein C (APC) has been introduced to reduce the high risk of death associated with severe sepsis or septic shock. This systematic review is an update of a Cochrane review originally published in 2007.Objectives: We assessed the benefits and harms of APC for patients with severe sepsis or septic shock. Published: 2012.

Systematic Review: Early goal-directed therapy in severe sepsis and septic shock: a contemporary review of the literature (2008)

Visit

Rivers EPC, V.; Whitmill, M.

Objective: Aggressive approaches to acute diseases such as acute myocardial infarction, trauma, and stroke have improved outcomes. Early goal-directed therapy for severe sepsis and septic shock represents a similar approach. An analysis of the literature assessing external validity and generalizability of this intervention is lacking. Published: 2008.